PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-85

  1. 9,810 Posts.
    lightbulb Created with Sketch. 1243
    Necessity will trump PR's personal reality

    He may just listen to Scott if he values his input
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.